If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
560.50    0.50 (0.09%)
Bid:
560.00
Ask:
561.00
Spread: 1.00 (0.179%)
Market Cap: £2.48b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

6 Jan 2023 14:00

RNS Number : 9615L
Tate & Lyle PLC
06 January 2023
 

Tate & Lyle PLC

 

Notification of transactions by Persons Discharging Managerial Responsibilities

 

Tate & Lyle PLC (the 'Company') has been informed that on 5 January 2023 the following transactions occurred by Persons Discharging Managerial Responsibilities ('PDMR'), in respect of their interest in ordinary shares of 29 1/6 pence each in the capital of the Company ('Shares') under the Dividend Reinvestment Plan ('DRIP').

 

PDMR

Number of Shares acquired under the DRIP

William Magee

188.716912

Andrew Taylor

1,596.896107

 

The notifications below, which have been made in accordance with the requirements of the UK Market Abuse Regulation, provide further detail.

 

Claire-Marie O'Grady

Company Secretary

6 January 2023

 

 

Notification and public disclosure of transaction by person discharging managerial responsibilities

 

Details of PDMR / person closely associated with them ("PCA")

a)

Name

William Magee

2.

Reason for the notification

a)

Position / status

President, Food & Beverage Solutions, North America

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

 

GB00BP92CJ43

b)

Nature of the transaction

Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

7.388527

188.716912

d)

Aggregated information

- Aggregated volume

- Price

 

 

188.716912

 

1,394.34 GBP

e)

Date of the transaction

2023-01-05

f)

Place of the transaction

London Stock ExchangeXLON

 

 

 

Notification and public disclosure of transaction by person discharging managerial responsibilities

 

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew Taylor

2.

Reason for the notification

a)

Position / status

President, Asia, Middle East, Africa and Latin America

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

 

GB00BP92CJ43

b)

Nature of the transaction

Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

7.388527

1596.896107

d)

Aggregated information

- Aggregated volume

- Price

 

 

1596.896107

 

11,798.71 GBP

e)

Date of the transaction

2023-01-05

f)

Place of the transaction

London Stock ExchangeXLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUNVRROUUARAR
Date   Source Headline
3rd Jul 202611:34 amRNSForm 8.5 (EPT/RI) - Tate & Lyle
3rd Jul 202611:28 amRNSForm 8.5 (EPT/RI)-TATE & LYLE PLC
3rd Jul 202611:23 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
3rd Jul 202611:20 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
3rd Jul 202611:09 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
3rd Jul 202611:00 amRNSForm 8.3 TATE & LYLE PLC
3rd Jul 202610:27 amRNSForm 8.3 - Tate & Lyle plc
3rd Jul 20269:19 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
3rd Jul 20267:00 amRNSScheme of Arrangement
3rd Jul 20267:00 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
2nd Jul 20263:30 pmRNSForm 8.3 - Tate & Lyle plc
2nd Jul 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
2nd Jul 20263:00 pmRNSForm 8.3 - Tate & Lyle plc
2nd Jul 202612:36 pmRNSForm 8.3 - Tate & Lyle plc
2nd Jul 202612:27 pmRNSForm 8.3 TATE & LYLE PLC
2nd Jul 202611:59 amRNSForm 8.3 - Tate & Lyle plc
2nd Jul 202611:31 amRNSForm 8.3 - Tate & Lyle plc
2nd Jul 202611:31 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
2nd Jul 202611:27 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
2nd Jul 202611:24 amRNSForm 8.3 Tate & Lyle Plc
2nd Jul 202611:23 amRNS20260701_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
2nd Jul 202611:23 amRNS20260701_TATE & LYLE_8.5 EPT RI_UK_MLI
2nd Jul 202611:19 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
2nd Jul 202611:18 amRNSForm 8.5 (EPT/RI)-TATE & LYLE PLC
2nd Jul 20269:35 amRNSForm 8.5 (EPT/RI)-Amendment
2nd Jul 20269:34 amRNSForm 8.5 (EPT/RI)
1st Jul 20263:25 pmRNSForm 8.3 TATE & LYLE PLC
1st Jul 20263:18 pmRNSForm 8.3 TATE & LYLE PLC
1st Jul 20263:14 pmRNSForm 8.3 - Tate & Lyle PLC
1st Jul 20263:12 pmRNSForm 8.3 - Tate & Lyle plc
1st Jul 20263:06 pmRNSForm 8.3 - Tate & Lyle plc
1st Jul 20262:32 pmRNSDirector/PDMR Shareholding
1st Jul 20262:27 pmRNSForm 8.3 - Tate & Lyle plc
1st Jul 20262:17 pmRNSForm 8.3 - Tate & Lyle plc
1st Jul 20262:13 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
1st Jul 20262:05 pmRNSForm 8.3 Tate & Lyle plc
1st Jul 20261:58 pmRNSForm 8.3 Tate & Lyle PLC
1st Jul 202612:33 pmRNSForm 8.3 - Tate & Lyle plc
1st Jul 202611:42 amRNSForm 8.5 (EPT/RI)-TATE & LYLE PLC
1st Jul 202611:39 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle plc
1st Jul 202611:33 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
1st Jul 202611:26 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
1st Jul 202611:10 amRNS20260630_TATE & LYLE_8.5 EPT RI_UK_MLI
1st Jul 202610:40 amRNSForm 8.3 Tate & Lyle Plc
1st Jul 20269:08 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
30th Jun 20263:29 pmRNSForm 8.3 TATE & LYLE PLC
30th Jun 20263:25 pmRNSForm 8.3 TATE & LYLE PLC
30th Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
30th Jun 20263:01 pmPRNInvesco Ltd: Form 8.3 - Tate & Lyle PLC; Public dealing disclosure
30th Jun 20263:00 pmRNSForm 8.3 - Tate & Lyle plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.